Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States.
Saved in:
| Title: | Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States. |
|---|---|
| Authors: | Shah HA; GSK, London, UK. hiral.a.shah@gsk.com.; Neisseria Portfolio, Value Evidence & Outcomes Team, 90 Great West Road, Brentford, TW8 9GS, UK. hiral.a.shah@gsk.com., Jutlla G; GSK, London, UK., Herrera-Restrepo O; GSK, Philadelphia, PA, USA., Graham J; RTI Health Solutions, Research Triangle Park, NC, USA., Hicks KA; RTI Health Solutions, Research Triangle Park, NC, USA., Carrico J; GSK, Durham, NC, USA., Grace M; RTI Health Solutions, Research Triangle Park, NC, USA., Clements DE; GSK, Philadelphia, PA, USA., Burman C; GSK, Philadelphia, PA, USA., Sohn WY; GSK, Rockville, MD, USA., Kuylen E; GSK, Wavre, Belgium., Begum S; GSK, London, UK., Kocaata Z; GSK, Wavre, Belgium. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2025 Mar; Vol. 43 (3), pp. 311-329. Date of Electronic Publication: 2024 Nov 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39585581 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shah+HA%22">Shah HA</searchLink>; GSK, London, UK. hiral.a.shah@gsk.com.; Neisseria Portfolio, Value Evidence & Outcomes Team, 90 Great West Road, Brentford, TW8 9GS, UK. hiral.a.shah@gsk.com.<br /><searchLink fieldCode="AU" term="%22Jutlla+G%22">Jutlla G</searchLink>; GSK, London, UK.<br /><searchLink fieldCode="AU" term="%22Herrera-Restrepo+O%22">Herrera-Restrepo O</searchLink>; GSK, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Graham+J%22">Graham J</searchLink>; RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hicks+KA%22">Hicks KA</searchLink>; RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Carrico+J%22">Carrico J</searchLink>; GSK, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Grace+M%22">Grace M</searchLink>; RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Clements+DE%22">Clements DE</searchLink>; GSK, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Burman+C%22">Burman C</searchLink>; GSK, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Sohn+WY%22">Sohn WY</searchLink>; GSK, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kuylen+E%22">Kuylen E</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Begum+S%22">Begum S</searchLink>; GSK, London, UK.<br /><searchLink fieldCode="AU" term="%22Kocaata+Z%22">Kocaata Z</searchLink>; GSK, Wavre, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2025 Mar; Vol. 43 (3), pp. 311-329. <i>Date of Electronic Publication: </i>2024 Nov 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39585581 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40273-024-01439-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 311 Titles: – TitleFull: Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shah HA – PersonEntity: Name: NameFull: Jutlla G – PersonEntity: Name: NameFull: Herrera-Restrepo O – PersonEntity: Name: NameFull: Graham J – PersonEntity: Name: NameFull: Hicks KA – PersonEntity: Name: NameFull: Carrico J – PersonEntity: Name: NameFull: Grace M – PersonEntity: Name: NameFull: Clements DE – PersonEntity: Name: NameFull: Burman C – PersonEntity: Name: NameFull: Sohn WY – PersonEntity: Name: NameFull: Kuylen E – PersonEntity: Name: NameFull: Begum S – PersonEntity: Name: NameFull: Kocaata Z IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1179-2027 Numbering: – Type: volume Value: 43 – Type: issue Value: 3 Titles: – TitleFull: PharmacoEconomics Type: main |
| ResultId | 1 |